Atherosclerosis News and Research

RSS
Atherosclerosis is the progressive buildup of plaque - the fatty deposits and other cells - in the inner walls of the arteries. The condition is a consequence of elevated cholesterol and for many it's a silent disease, with no visible signs or symptoms. The disease can begin in early adulthood and continues to progress for the rest of a person's life. Despite the serious nature of atherosclerosis, many people do not understand how it develops and progresses.
Calorie restriction may help people to lead longer and healthier lives

Calorie restriction may help people to lead longer and healthier lives

New findings may aid in developing medications for atherosclerosis and insulin resistance

New findings may aid in developing medications for atherosclerosis and insulin resistance

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

VBL Therapeutics announces upcoming presentations at premier dermatology and cancer research meetings

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

Survey reveals Gamunex as preferred IGIV therapy among neurologists

Survey reveals Gamunex as preferred IGIV therapy among neurologists

Genes influence chronic kidney disease risk: Research

Genes influence chronic kidney disease risk: Research

Obese children have stiffer arteries than leaner counterparts

Obese children have stiffer arteries than leaner counterparts

Results of research study on the expression of KIF6 in mouse model

Results of research study on the expression of KIF6 in mouse model

Resverlogix highlights features of RVX-208 drug at ATVB conference

Resverlogix highlights features of RVX-208 drug at ATVB conference

PESA CNIC-Santander trial initiative to increase knowledge about cardiovascular diseases

PESA CNIC-Santander trial initiative to increase knowledge about cardiovascular diseases

Idera Pharmaceuticals' TLR antagonists exert anti atherogenic effects in preclinical model of atherosclerosis

Idera Pharmaceuticals' TLR antagonists exert anti atherogenic effects in preclinical model of atherosclerosis

LA BioMed to receive $9.7M federal grant for construction of new Chronic Disease Clinical Research Center

LA BioMed to receive $9.7M federal grant for construction of new Chronic Disease Clinical Research Center

Obstructive sleep apnea associated with increased risk of stroke in men

Obstructive sleep apnea associated with increased risk of stroke in men

Ultrasound scan of carotid artery improves prediction of heart disease: Research

Ultrasound scan of carotid artery improves prediction of heart disease: Research

Comprehensive cardiac health study provides superior results

Comprehensive cardiac health study provides superior results

Endovascular aortic abdominal aneurysm repair utilization associated with disease prevalence

Endovascular aortic abdominal aneurysm repair utilization associated with disease prevalence

AFFiRiS AG develops PD01 vaccine for Parkinson's disease

AFFiRiS AG develops PD01 vaccine for Parkinson's disease

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Plaques in blood vessels may break by overproducing protein-digesting enzymes

Plaques in blood vessels may break by overproducing protein-digesting enzymes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.